Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients
dc.contributor.author | Remzi, Mesut | en_US |
dc.contributor.author | Haitel, Andrea | en_US |
dc.contributor.author | Margulis, Vitaly | en_US |
dc.contributor.author | Karakiewizc, Pierre | en_US |
dc.contributor.author | Montorsi, Francesco | en_US |
dc.contributor.author | Kikuchi, Eiji | en_US |
dc.contributor.author | Zigeuner, Richard | en_US |
dc.contributor.author | Weizer, Alon Z. | en_US |
dc.contributor.author | Bolenz, Christian | en_US |
dc.contributor.author | Bensalah, Karim | en_US |
dc.contributor.author | Suardi, Nazareno | en_US |
dc.contributor.author | Raman, Jay D. | en_US |
dc.contributor.author | Lotan, Yair | en_US |
dc.contributor.author | Waldert, Matthias | en_US |
dc.contributor.author | Ng, Casey K. | en_US |
dc.contributor.author | Fernández, Mario I. | en_US |
dc.contributor.author | Koppie, Theresa M. | en_US |
dc.contributor.author | Ströbel, Philipp | en_US |
dc.contributor.author | Kabbani, Wareef | en_US |
dc.contributor.author | Murai, Masaru | en_US |
dc.contributor.author | Langner, Cord | en_US |
dc.contributor.author | Roscigno, Marco | en_US |
dc.contributor.author | Wheat, Jeffrey C. | en_US |
dc.contributor.author | Guo, Charles C. | en_US |
dc.contributor.author | Wood, Christopher G. | en_US |
dc.contributor.author | Shariat, Shahrokh F. | en_US |
dc.date.accessioned | 2010-06-01T19:04:09Z | |
dc.date.available | 2010-06-01T19:04:09Z | |
dc.date.issued | 2009-02 | en_US |
dc.identifier.citation | Remzi, Mesut; Haitel, Andrea; Margulis, Vitaly; Karakiewizc, Pierre; Montorsi, Francesco; Kikuchi, Eiji; Zigeuner, Richard; Weizer, Alon; Bolenz, Christian; Bensalah, Karim; Suardi, Nazareno; Raman, Jay D.; Lotan, Yair; Waldert, Matthias; Ng, Casey K.; FernÁndez, Mario; Koppie, Theresa M.; StrÖbel, Philipp; Kabbani, Wareef; Murai, Masaru; Langner, Cord; Roscigno, Marco; Wheat, Jeffrey; Guo, Charles C.; Wood, Christopher G.; Shariat, Shahrokh F. (2009). "Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients." BJU International 103(3): 307-311. <http://hdl.handle.net/2027.42/72257> | en_US |
dc.identifier.issn | 1464-4096 | en_US |
dc.identifier.issn | 1464-410X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/72257 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18990163&dopt=citation | en_US |
dc.description.abstract | To assess whether tumour architecture can help to refine the prognosis of patients treated with nephroureterectomy (NU) for urothelial carcinoma (UC) of the upper urinary tract (UT), as the prognostic value of tumour architecture (papillary vs sessile) in UTUC remains elusive. PATIENTS AND METHODS The study included 1363 patients with UTUC and treated with radical NU at 12 centres worldwide. All slides were re-reviewed according to strict criteria by genitourinary pathologists who were unaware of the findings of the original pathology slides and clinical outcomes. Gross tumour architecture was categorized as sessile vs papillary. RESULTS Papillary growth was identified in 983 patients (72.2%) and sessile growth in 380 (27.8%). The sessile growth pattern was associated with higher tumour grade, more advanced stage, lymphovascular invasion, and metastasis to lymph nodes (all P < 0.001). In multivariable Cox regression analyses that adjusted for the effects of pathological stage, grade and lymph node status, tumour architecture (sessile or papillary) was an independent predictor of cancer recurrence (hazard ratio 1.5, P = 0.002) and cancer-specific mortality (1.6, P = 0.001). Adding tumour architecture increased the predictive accuracy of a model that comprised pathological stage, grade and lymph node status for predicting cancer recurrence and cancer-specific death by a minimal but statistically significant margin (gain in predictive accuracy 1% and 0.5%, both P < 0.001). CONCLUSION The tumour architecture of UTUC is associated with established features of biologically aggressive disease, and more importantly, with prognosis after radical NU. Including tumour architecture in predictive models for disease progression should be considered, aiming to identify patients who might benefit from early systemic therapeutic intervention. | en_US |
dc.format.extent | 213025 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | © 2009 BJU International | en_US |
dc.subject.other | Urothelial Carcinoma | en_US |
dc.subject.other | Urinary Tract Cancer | en_US |
dc.subject.other | Architecture | en_US |
dc.subject.other | Recurrence | en_US |
dc.subject.other | Survival | en_US |
dc.title | Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, MI, USA, | en_US |
dc.contributor.affiliationother | University of Texas MD Anderson Cancer Center, Houston, TX, USA, | en_US |
dc.contributor.affiliationother | University of Montreal, Montreal, Quebec, Canada, | en_US |
dc.contributor.affiliationother | Vita-Salute University, Milan, Italy, | en_US |
dc.contributor.affiliationother | Keio University School of Medicine, Tokyo, Japan, | en_US |
dc.contributor.affiliationother | Medical University Graz, Graz, Austria, | en_US |
dc.contributor.affiliationother | UniversitÄtsklinikum Mannheim, Mannheim, Germany, | en_US |
dc.contributor.affiliationother | University of Rennes, Rennes, France, | en_US |
dc.contributor.affiliationother | Cornell University, New York, NY, USA, | en_US |
dc.contributor.affiliationother | University of Texas Southwestern Dallas, TX, USA, | en_US |
dc.contributor.affiliationother | Clinica Alemana de Santiago, Santiago de Chile, Chile, | en_US |
dc.contributor.affiliationother | University of California Davis, Sacramento, CA, USA | en_US |
dc.identifier.pmid | 18990163 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/72257/1/j.1464-410X.2008.08003.x.pdf | |
dc.identifier.doi | 10.1111/j.1464-410X.2008.08003.x | en_US |
dc.identifier.source | BJU International | en_US |
dc.identifier.citedreference | Guinan P, Vogelzang NJ, Randazzo R et al. Renal pelvic cancer: a review of 611 patients treated in Illinois 1975–85. Cancer Incidence and End Results Committee. Urology 1992; 40: 393 – 9 | en_US |
dc.identifier.citedreference | Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998; 52: 594 – 601 | en_US |
dc.identifier.citedreference | Remzi M, MÜller L, Klingler HC et al. Mid-term follow up (5 years) of laparoscopic nephroureterectomy compared to open nephroureterectomy for upper urinary tract transitional cell cancer. Eur Urol Suppl 2007; 6: A794 | en_US |
dc.identifier.citedreference | Novara G, De Marco V, Gottardo F et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 2007; 110: 1715 – 22 | en_US |
dc.identifier.citedreference | Tosoni I, Wagner U, Sauter G et al. Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int 2000; 85: 48 – 53 | en_US |
dc.identifier.citedreference | Bol MG, Baak JP, Buhr-Wildhagen S et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 2003; 169: 1291 – 4 | en_US |
dc.identifier.citedreference | Epstein JI, Amin MB, Reuter VR, Mostofi FK. The Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder. Am J Surg Pathol 1998; 22: 1435 – 48 | en_US |
dc.identifier.citedreference | Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982; 247: 2543 – 6 | en_US |
dc.identifier.citedreference | Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361 – 87 | en_US |
dc.identifier.citedreference | KrÜger S, Noack F, BÖhle A, Feller AC. Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder. Oncol Rep 2004; 12: 609 – 13 | en_US |
dc.identifier.citedreference | Langner C, Hutterer G, Chromecki T, Rehak P, Zigeuner R. Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch 2006; 448: 604 – 11 | en_US |
dc.identifier.citedreference | Jimenez RE, Gheiler E, Oskanian P et al. Grading the incasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 2000; 24: 980 – 7 | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.